-
1
-
-
27944456516
-
Managing patients treated with bevacizumab combination therapy
-
DOI 10.1159/000088481
-
Gordon MS, Cunningham D. Managing patients treated with bevacizumab combination therapy. Oncology 2005; 69(Suppl 3) : 25-33. (Pubitemid 41680950)
-
(2005)
Oncology
, vol.69
, Issue.SUPPL. 3
, pp. 25-33
-
-
Gordon, M.S.1
Cunningham, D.2
-
2
-
-
0042343801
-
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
-
DOI 10.1056/NEJMoa021491
-
Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX, Rosenberg SA. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003; 349 : 427-434. (Pubitemid 36910021)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.5
, pp. 427-434
-
-
Yang, J.C.1
Haworth, L.2
Sherry, R.M.3
Hwu, P.4
Schwartzentruber, D.J.5
Topalian, S.L.6
Steinberg, S.M.7
Chen, H.X.8
Rosenberg, S.A.9
-
3
-
-
72449132908
-
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
-
Izzedine H, Massard C, Spano JP, Goldwasser F, Khayat D, Soria JC. VEGF signalling inhibition-induced proteinuria : Mechanisms, significance and management. Eur J Cancer 2010; 46 : 439-448.
-
(2010)
Eur J Cancer
, vol.46
, pp. 439-448
-
-
Izzedine, H.1
Massard, C.2
Spano, J.P.3
Goldwasser, F.4
Khayat, D.5
Soria, J.C.6
-
4
-
-
40849130173
-
VEGF inhibition and renal thrombotic microangiopathy
-
DOI 10.1056/NEJMoa0707330
-
Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358 : 1129-1136. (Pubitemid 351398487)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.11
, pp. 1129-1136
-
-
Eremina, V.1
Jefferson, J.A.2
Kowalewska, J.3
Hochster, H.4
Haas, M.5
Weisstuch, J.6
Richardson, C.7
Kopp, J.B.8
Kabir, M.G.9
Backx, P.H.10
Gerber, H.-P.11
Ferrara, N.12
Barisoni, L.13
Alpers, C.E.14
Quaggin, S.E.15
-
5
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
-
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111 : 649-658.
-
(2003)
J Clin Invest
, vol.111
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.Y.2
Merchan, J.3
Lim, K.H.4
Li, J.5
Mondal, S.6
Libermann, T.A.7
Morgan, J.P.8
Sellke, F.W.9
Stillman, I.E.10
Epstein, F.H.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
6
-
-
84875718770
-
Renal involvement in preeclampsia: Similarities to VEGF ablation therapy
-
Epub 2010 Dec 23
-
Müller-Deile J, Schiffer M. Renal involvement in preeclampsia : similarities to VEGF ablation therapy. J Pregnancy 2011. Epub 2010 Dec 23.
-
(2011)
J Pregnancy
-
-
Müller-Deile, J.1
Schiffer, M.2
-
7
-
-
77955638572
-
Bevacizumab increases risk for severe proteinuria in cancer patients
-
Wu S, Kim C, Baer L, Zhu X. Bevacizumab increases risk for severe proteinuria in cancer patients. J Am Soc Nephrol 2010; 21 : 1381-1389.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 1381-1389
-
-
Wu, S.1
Kim, C.2
Baer, L.3
Zhu, X.4
-
8
-
-
34247597779
-
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma
-
DOI 10.1038/ncpneph0476, PII NCPNEPH0476
-
Roncone D, Satoskar A, Nadasdy T, Monk JP, Rovin BH. Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol 2007; 3 : 287-293. (Pubitemid 46674523)
-
(2007)
Nature Clinical Practice Nephrology
, vol.3
, Issue.5
, pp. 287-293
-
-
Roncone, D.1
Satoskar, A.2
Nadasdy, T.3
Monk, J.P.4
Rovin, B.H.5
-
9
-
-
56549115248
-
Glomerular disease related to anti-VEGF therapy
-
Stokes MB, Erazo MC, D'Agati VD. Glomerular disease related to anti-VEGF therapy. Kidney Int 2008; 74 : 1487-1491.
-
(2008)
Kidney Int
, vol.74
, pp. 1487-1491
-
-
Stokes, M.B.1
Erazo, M.C.2
D'Agati, V.D.3
-
10
-
-
84887111782
-
Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: A case report and review of the literature
-
Yahata M, Nakaya I, Sakuma T, Sato H, Aoki S, Soma J. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer : a case report and review of the literature. BMC Res Notes 2013; 6 : 450.
-
(2013)
BMC Res Notes
, vol.6
, pp. 450
-
-
Yahata, M.1
Nakaya, I.2
Sakuma, T.3
Sato, H.4
Aoki, S.5
Soma, J.6
-
11
-
-
83355172763
-
Gastroduodenal, intestinal and colonic permeability during anticancer therapy
-
Melichar B, Hyspler R, Kalábová H, Dvorák J, Tichá A, Zadák Z. Gastroduodenal, intestinal and colonic permeability during anticancer therapy. Hepatogastroenterology 2011; 58 : 1193-1199.
-
(2011)
Hepatogastroenterology
, vol.58
, pp. 1193-1199
-
-
Melichar, B.1
Hyspler, R.2
Kalábová, H.3
Dvorák, J.4
Tichá, A.5
Zadák, Z.6
-
12
-
-
0023243536
-
Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy
-
Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis 1987; 9 : 404-409. (Pubitemid 17090638)
-
(1987)
American Journal of Kidney Diseases
, vol.9
, Issue.5
, pp. 404-409
-
-
Yoshimura, M.1
Kida, H.2
Abe, T.3
-
13
-
-
0024603582
-
Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data
-
Lee HS, Choi Y, Lee JS, Yu BH, Koh HI. Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data. Kidney Int 1989; 35 : 880-886. (Pubitemid 19082118)
-
(1989)
Kidney International
, vol.35
, Issue.3
, pp. 880-886
-
-
Lee, H.S.1
Choi, Y.2
Lee, J.S.3
Yu, B.H.4
Koh, H.I.5
-
14
-
-
0019370295
-
Monocytes and human renal glomerular disease. A quantitative evaluation
-
Magil AB, Wadsworth LD, Loewen M. Monocytes and human renal glomerular disease. A quantitative evaluation. Lab Invest 1981; 44 : 27-33. (Pubitemid 11191653)
-
(1981)
Laboratory Investigation
, vol.44
, Issue.1
, pp. 27-33
-
-
Magil, A.B.1
Wadsworth, L.D.2
Loewen, M.3
-
15
-
-
84906273762
-
-
Japanese source
-
-
-
-
16
-
-
0019408838
-
Monocytes in human glomerulonephritis. An electron microscopic study
-
Magil AB, Wadsworth LD. Monocytes in human glomerulonephritis. An electron microscopic study. Lab Invest 1981; 45 : 77-81. (Pubitemid 11079854)
-
(1981)
Laboratory Investigation
, vol.45
, Issue.1
, pp. 77-81
-
-
Magil, A.B.1
Wadsworth, L.D.2
-
17
-
-
0031605320
-
Macrophages in renal injury
-
Atkins RC. Macrophages in renal injury. Am J Kidney Dis 1998; 31 : xlv-xlvii.
-
(1998)
Am J Kidney Dis
, vol.31
-
-
Atkins, R.C.1
-
18
-
-
84906254239
-
-
Japanese source
-
-
-
-
19
-
-
78651398351
-
Macrophages in renal disease
-
Wang Y, Harris DC. Macrophages in renal disease. J Am Soc Nephrol 2011; 22 : 21-27.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 21-27
-
-
Wang, Y.1
Harris, D.C.2
|